The 14th edition EMD Serono’s Specialty Digest continues its. Getting the picture of what’s happening now is the value of. Managed Markets, EMD Serono, Inc. Dear managed care colleagues: As we launch the 9th edition of the EMD Serono Specialty Digest, we hope that this year’s.
|Published (Last):||18 July 2018|
|PDF File Size:||18.23 Mb|
|ePub File Size:||14.2 Mb|
|Price:||Free* [*Free Regsitration Required]|
Decline in Death Rates. The Costs of Chronic Disease. Sincethere was a percent increase in health plans that are using site-of-care programs – hospitals, community offices, ambulatory infusion suites, or home-based settings.
Better Use of Medicines. Drug Discovery and Development.
12th Edition of the EMD Serono Specialty Digest™ Now Available
Increases in US Life Expectancy. Total Health Care Spending Growth. Leading in Intellectual Property.
Stepping Stones for Innovation. The sample included commercial health plan personnel who are responsible for specialty drug-related services and responded to emailed invitations from Artemetrx Specialty Drug Solutions.
Decline in New Medicine Returns. Significant Value to Communities. State Targeting in Economic Plans. The Complexity of Clinical Trials. Most Common Prescribing Problem. Value From Better Use of Medicines. Of those that do not have a site-of-care program, more than half plan to implement one in the next 12 months.
Clinical Factors Drive Presciptions. Patent Challenges by Generics. The founding family remains the majority owner of the publicly listed corporate group. Use of Generic Medicines. Table of contents Easily move through the document, finding the part you want in the convenient table of contents. Commercial Success of Approved Meds.
Brand Medicine Spending Rebates. Medicines Improve Quality of Life. Patients Facing High Cost Sharing. Slowdown in Medicine Spending.
EMD Serono Specialty Digest
The specialty pharmacy landscape is always changing. Medicine Spending in Next Decade. ConvergX, February, Calgary, Canada. Medicines Offer Cost Containment. Translating Science into Medicines. Brand Sales Face Competition. Reductions in Hep C Complications. Drug Development Costs Doubling.
PhRMA | Chart Packs
Search keyword Search for words or phrases and see all the search results digedt away. A Decade of Advances. Greater Access to Cancer Medicines. For more than 40 years, the business has integrated cutting-edge science, innovative products and industry-leading patient support and access programs. Pragmatic Solutions to Address Cost.
Growth in Medicine Prices.
High Cost Sharing Reduces Adherence. Innovation in Rare Diseases. Challenging the US in Innovation. Furthermore, most plans 78 percent require injectable drugs for MS to be dispensed through a contracted specialty pharmacy provider SPP.
View original content with multimedia: Market for Is Medicines Changing. Find out what’s going to be top of mind in the coming year. Astronics – Systemes Luminescent Canada Inc.
Among the interesting trends identified this year: Welcome to our new site. Seventy-six percent of plans cover injectable drugs under seeono pharmacy benefit only. The Digest is available to those who request a copy at http: